title: Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic grade.
authors.affiliation: Department of Pathology, University of Maryland School of Medicine, Baltimore, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Papadimitriou
authors.forename: A
authors.initials: A
authors.lastname: Wiland
authors.forename: C B
authors.initials: CB
authors.lastname: Drachenberg
authors.forename: D K
authors.initials: DK
authors.lastname: Klassen
authors.forename: S T
authors.initials: ST
authors.lastname: Bartlett
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence
chemical_list: D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D011241:Prednisone